Aurobindo completes acquisition of Natrol
Will pay US$132.5m for the nutritional supplements manufacturer
Aurobindo Pharma, a genetics and active pharmaceutical ingredients manufacturer headquartered in Hyderabad, India, has bought the assets Natrol through its subsidiary Aurobindo Pharma USA.
The company says Dayton, New Jersey-based Aurobindo Pharma USA emerged as the highest bidder to acquire the nutritional supplements manufacturer. The bid, worth US$132.5m with an agreement to take over certain liabilities, will now have to be finally approved by the US Bankruptcy Court for the District of Delaware.
'I am pleased that Aurobindo recognises the values of Natrol’s uncompromised quality products, loyal customers, talented employees and solid relationships with our retailer partners,' said Mesrop Khoudagoulian, Chief Executive of Natrol.
'We look forward to working with the Aurobindo team to further expand our over-the-counter product portfolio and our reach with the financial support of strong owners.'
N Govindarajan, Managing Director of Aurobindo, added: 'Natrol comes with certain well established brands and an extensive distribution network consisting of retail pharmacy chains and speciality healthfood stores, to help us tactically position ourselves in the US nutraceuticals space and offer an effective growth strategy to expand market penetration going forward.’
Natrol offers branded products including vitamins, minerals, and supplements; diet and weight management products; sports nutrition products; and products and formulas for hair, skin, and nails.
